Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Paclitaxel-eluting Stent Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Metal Stent
      • 1.3.3 Polymer Stent
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Paclitaxel-eluting Stent Market Share by Application (2019-2025)
      • 1.4.2 Coronary Heart Disease
      • 1.4.3 Clinical
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Paclitaxel-eluting Stent Production Value 2014-2025
      • 2.1.2 Global Paclitaxel-eluting Stent Production 2014-2025
      • 2.1.3 Global Paclitaxel-eluting Stent Capacity 2014-2025
      • 2.1.4 Global Paclitaxel-eluting Stent Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Paclitaxel-eluting Stent Market Size CAGR of Key Regions
      • 2.2.2 Global Paclitaxel-eluting Stent Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Paclitaxel-eluting Stent Capacity by Manufacturers
      • 3.1.2 Global Paclitaxel-eluting Stent Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Paclitaxel-eluting Stent Revenue by Manufacturers (2014-2019)
      • 3.2.2 Paclitaxel-eluting Stent Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Paclitaxel-eluting Stent Market Concentration Ratio (CR5 and HHI)
    • 3.3 Paclitaxel-eluting Stent Price by Manufacturers
    • 3.4 Key Manufacturers Paclitaxel-eluting Stent Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Paclitaxel-eluting Stent Market
    • 3.6 Key Manufacturers Paclitaxel-eluting Stent Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Metal Stent Production and Production Value (2014-2019)
      • 4.1.2 Polymer Stent Production and Production Value (2014-2019)
      • 4.1.3 Others Production and Production Value (2014-2019)
    • 4.2 Global Paclitaxel-eluting Stent Production Market Share by Type
    • 4.3 Global Paclitaxel-eluting Stent Production Value Market Share by Type
    • 4.4 Paclitaxel-eluting Stent Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Paclitaxel-eluting Stent Consumption by Application

    6 Production by Regions

    • 6.1 Global Paclitaxel-eluting Stent Production (History Data) by Regions 2014-2019
    • 6.2 Global Paclitaxel-eluting Stent Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Paclitaxel-eluting Stent Production Growth Rate 2014-2019
      • 6.3.2 United States Paclitaxel-eluting Stent Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Paclitaxel-eluting Stent Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Paclitaxel-eluting Stent Production Growth Rate 2014-2019
      • 6.4.2 European Union Paclitaxel-eluting Stent Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Paclitaxel-eluting Stent Import & Export
    • 6.5 China
      • 6.5.1 China Paclitaxel-eluting Stent Production Growth Rate 2014-2019
      • 6.5.2 China Paclitaxel-eluting Stent Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Paclitaxel-eluting Stent Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Paclitaxel-eluting Stent Consumption by Regions

    • 7.1 Global Paclitaxel-eluting Stent Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Paclitaxel-eluting Stent Consumption by Type
      • 7.2.2 United States Paclitaxel-eluting Stent Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Paclitaxel-eluting Stent Consumption by Type
      • 7.3.2 European Union Paclitaxel-eluting Stent Consumption by Application
    • 7.4 China
      • 7.4.1 China Paclitaxel-eluting Stent Consumption by Type
      • 7.4.2 China Paclitaxel-eluting Stent Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Paclitaxel-eluting Stent Consumption by Type
      • 7.5.2 Rest of World Paclitaxel-eluting Stent Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 B.Braun Melsengen AG
      • 8.1.1 B.Braun Melsengen AG Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.1.4 Paclitaxel-eluting Stent Product Introduction
      • 8.1.5 B.Braun Melsengen AG Recent Development
    • 8.2 Biosensors
      • 8.2.1 Biosensors Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.2.4 Paclitaxel-eluting Stent Product Introduction
      • 8.2.5 Biosensors Recent Development
    • 8.3 Biotronik
      • 8.3.1 Biotronik Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.3.4 Paclitaxel-eluting Stent Product Introduction
      • 8.3.5 Biotronik Recent Development
    • 8.4 Blue Medical
      • 8.4.1 Blue Medical Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.4.4 Paclitaxel-eluting Stent Product Introduction
      • 8.4.5 Blue Medical Recent Development
    • 8.5 Boston Scientific
      • 8.5.1 Boston Scientific Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.5.4 Paclitaxel-eluting Stent Product Introduction
      • 8.5.5 Boston Scientific Recent Development
    • 8.6 DISA Vascular
      • 8.6.1 DISA Vascular Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.6.4 Paclitaxel-eluting Stent Product Introduction
      • 8.6.5 DISA Vascular Recent Development
    • 8.7 Essen
      • 8.7.1 Essen Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.7.4 Paclitaxel-eluting Stent Product Introduction
      • 8.7.5 Essen Recent Development
    • 8.8 Medtronic Vascular
      • 8.8.1 Medtronic Vascular Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.8.4 Paclitaxel-eluting Stent Product Introduction
      • 8.8.5 Medtronic Vascular Recent Development
    • 8.9 MicroPort Medical
      • 8.9.1 MicroPort Medical Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.9.4 Paclitaxel-eluting Stent Product Introduction
      • 8.9.5 MicroPort Medical Recent Development
    • 8.10 Terumo Medical
      • 8.10.1 Terumo Medical Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Paclitaxel-eluting Stent
      • 8.10.4 Paclitaxel-eluting Stent Product Introduction
      • 8.10.5 Terumo Medical Recent Development
    • 8.11 Orbusneich

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Paclitaxel-eluting Stent Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Paclitaxel-eluting Stent Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Paclitaxel-eluting Stent Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Paclitaxel-eluting Stent Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Paclitaxel-eluting Stent Production Forecast by Type
      • 9.7.2 Global Paclitaxel-eluting Stent Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Paclitaxel-eluting Stent Sales Channels
      • 10.2.2 Paclitaxel-eluting Stent Distributors
    • 10.3 Paclitaxel-eluting Stent Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
      In 2019, the market size of Paclitaxel-eluting Stent is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Paclitaxel-eluting Stent.

      This report studies the global market size of Paclitaxel-eluting Stent, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Paclitaxel-eluting Stent production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      B.Braun Melsengen AG
      Biosensors
      Biotronik
      Blue Medical
      Boston Scientific
      DISA Vascular
      Essen
      Medtronic Vascular
      MicroPort Medical
      Terumo Medical
      Orbusneich

      Market Segment by Product Type
      Metal Stent
      Polymer Stent
      Others

      Market Segment by Application
      Coronary Heart Disease
      Clinical
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Paclitaxel-eluting Stent status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Paclitaxel-eluting Stent manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Paclitaxel-eluting Stent are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now